A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure.
Journal
HemaSphere
ISSN: 2572-9241
Titre abrégé: Hemasphere
Pays: United States
ID NLM: 101740619
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
11
03
2020
accepted:
21
04
2020
entrez:
11
7
2020
pubmed:
11
7
2020
medline:
11
7
2020
Statut:
epublish
Résumé
This single-center prospective clinical trial evaluated the combination of nivolumab plus bendamustine (NB) as a salvage regimen in classical Hodgkin lymphoma patients after failure of nivolumab monotherapy. A total of 30 patients received nivolumab (3 mg/kg) on D1,14 and bendamustine (90 mg/m
Identifiants
pubmed: 32647803
doi: 10.1097/HS9.0000000000000401
pii: HemaSphere-2020-0082
pmc: PMC7306298
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e401Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.
Références
J Clin Oncol. 2018 May 10;36(14):1428-1439
pubmed: 29584546
Oncologist. 2020 Oct;25(10):878-885
pubmed: 32720734
Lancet Oncol. 2016 Sep;17(9):1283-94
pubmed: 27451390
J Clin Oncol. 2013 Feb 1;31(4):456-60
pubmed: 23248254
J Clin Oncol. 2013 Feb 20;31(6):684-91
pubmed: 23182987
Blood. 2018 Mar 15;131(11):1183-1194
pubmed: 29229594
Ther Adv Med Oncol. 2018 Apr 06;10:1758835918762094
pubmed: 29662546
Leuk Lymphoma. 2013 Nov;54(11):2531-3
pubmed: 23617324
Clin Cancer Res. 2008 Jan 1;14(1):309-17
pubmed: 18172283
Leuk Lymphoma. 2019 Sep;60(9):2316-2319
pubmed: 30712423
J Immunol. 2013 Jun 1;190(11):5620-8
pubmed: 23616570
Br J Cancer. 2010 Jan 5;102(1):115-23
pubmed: 19997099
Lancet. 2002 Jun 15;359(9323):2065-71
pubmed: 12086759
J Clin Oncol. 2012 Jun 20;30(18):2183-9
pubmed: 22454421
Cancer Res. 2015 Dec 1;75(23):5034-45
pubmed: 26573793
Blood. 2010 Oct 28;116(17):3268-77
pubmed: 20628145
Blood. 2016 Sep 22;128(12):1562-6
pubmed: 27432875
Blood. 2017 Mar 9;129(10):1380-1388
pubmed: 28073785
Am J Hematol. 2018 Jun 8;:
pubmed: 29884994
Blood. 2019 Oct 3;134(14):1144-1153
pubmed: 31409671